Todd Boudreaux, VP of Strategic Partnerships
2016-09-02
Todd was diagnosed with Type 1 diabetes in 2000, and has been unofficially advocating for T1D ever since. Before joining the team at Beyond Type 1, Todd wrote and produced television shows for Discovery Channel, Travel Channel and Animal Planet. When he’s not in the office, you can usually find him at a baseball game, traveling or drawing on his Etch A Sketch. You can also follow him on Instagram @toddboo.
Written by Todd
Using a Smart Pen While on a Pump Break
Everyone could use a break now and then, but taking off a pump doesn't mean abandoning technology all together. MORE
Looking Back: Nick Jonas Reflects on his T1D Diagnosis
On the day of his diaversary, Nick Jonas opens up about details of his own type 1 diabetes diagnosis in an interview with Beyond Type 1.MORE
The Benefits of Using a Smart Insulin Pen
Endocrinologist Anne Peters, MD. discusses the benefits of using a smart pen to help you manage insulin doses for type 1 or type 2 diabetes.MORE
Dedicated to Helping People With T1D: Dr. Gary Meininger on His Life and Career with Diabetes
We spoke with Dr. Meininger on his personal connection to T1D, his role at Vertex, and important work being done in clinical trials.MORE
Lilly Announces Lower List price for Insulin Lispro
The company will lower the list price of the generic version of Humalog in the U.S. by an additional 40 percent starting January 1, 2022.MORE
Lilly Issues Voluntary Nationwide Recall of One Lot of Glucagon Emergency Kit
Lilly announced the voluntary recall of lot D239382D, Expiration April 2022 of Glucagon Emergency Kits.MORE
The Future of Glucagon with Xeris Pharmaceuticals CEO Paul Edick
Beyond Type 1 recently sat down with Xeris Pharmaceuticals CEO Paul Edick to discuss the availability of their ready-to-use glucagon products, how the company was affected by the COVID-19 pandemic, an...MORE
The Frightening Reality of Skyrocketing T1D Diagnoses in Mali
Data from 2007 would suggest that T1D was extremely rare in the land-locked West-African country. The reality is far more grim.MORE
Dr. Michael Haller on Clinical Research and Future Treatments for T1D
Dr. Haller discusses his career in endocrinology, the importance of clinical research, and some of the more exciting T1D research underway.MORE
A New Way of Looking at Beta Cells with Peter Thompson
Dr. Thompson recently spoke with BT1 about the work he did through the DRC, and what he's been up to since returning to Canada. MORE
‘Diversity in Diabetes’, an Organization Addressing Disparities Head-on
Quisha Umemba, co-founder of 'Diversity in Diabetes' spoke with Beyond Type 1 about disparities in diabetes treatment, technology and more. MORE
JDRF Launches Program to Advance Universal Screening for Type 1 Diabetes
T1Detect is a new screening initiative designed to make early detection of type 1 diabetes easier and more accessible to a broad population. MORE
Fourth Major Insulin Manufacturer Enters US Market with Semglee Launch
Semglee (insulin glargine), from Mylan and Biocon, is now available by prescription in the United States in vial and pre-filled pen presentations.MORE
Going Virtual: The Future of Diabetes Care
Ashlyn Mills talks to Beyond Type 1 about her experience with seeing an endocrinologist virtually through DreaMed Diabetes. MORE
White House Issues Executive Orders Taking Aim at Drug Prices
On Friday, July 24 President Trump announced and signed four Executive Orders aimed at lowering prescription drug prices in the U.S.MORE
What Will Back to School Look Like During COVID-19?
Anne Peters, MD shares her thoughts on the re-opening of schools, whether COVID-19 is harmful for children, and how to be as safe as possible.MORE
One Drop Announces New Overnight Hypo Predictions and Long-Term Health Forecasts at ADA 2020
One Drop unveiled new AI-powered predictions for blood glucose, A1C, blood pressure, and weight up to six months in advanceMORE
How to Measure Success in Pediatric Diabetes Care
In a spirited debate, speakers made their case for whether the primary metric for pediatric diabetes success should be A1C or Time in Range (TIR).MORE
Nationwide Study in France Shows Dramatic Drop in DKA in Type 1 and Type 2 After Starting on FreeStyle Libre
The study included more that 70,000 patients living with diabetes and DKA rates were reduced by 52% for patients with T1D and 47% for patients with T2D.MORE
Closed Loop Updates: Omnipod Horizon and Medtronic 780G data presented at ADA 2020
Data from four new clinical trials involving Hybrid Closed Loop systems, Medtronic 780G and Omnipod 5 Powered by Horizon was presented at ADA 2020.MORE
IndyCar Driver Charlie Kimball Talks COVID-19 + Racing with T1D
Indy racecar driver Charlie Kimball lives with type 1 diabetes and talks about what's ahead for this season and how it's been impacted by the coronavirus pandemic.MORE
“Jesse Was Here (More Lasagna, Please): Feeding the Soul of a Grieving Mother” Book Review
In a new book, Michelle Bauer recounts her son Jesse’s life with T1D, interactions following his death, and practical advice for those experiencing grief.MORE
COVID-19 Antibody Tests, When to Seek Emergency Care, Hydroxychloroquine + More with Dr. Anne Peters
Dr. Peters spoke with BT1 about the unreliability of current COVID-19 antibody tests, when to seek emergency care, hydroxychloroquine use and more.MORE
New Program Offers $35 Monthly Copays for Lilly Insulins
Eli Lilly announced a new program that allows people in the US to fill their monthly prescription of Lilly insulin for $35 per month with a copay card.MORE
T1D + COVID-19 Positive—One Nurse’s Story
Ashlee shares her experience having now had COVID-19, and what it means as a healthcare professional and a person living with type 1 diabetes.MORE
The Latest on COVID-19 From Dr. Anne Peters
Dr. Anne Peters took time to check in about COVID-19 and give us her latest updates, especially pertaining to diabetes care as this situation is unfolding.MORE
A Deeper Look at Beta Cell Research with Frank Martin
Frank Martin is a Director of Research at JDRF, focusing on beta cell therapy. Recently he spoke with Beyond Type 1 about JDRF’s mission to cure T1D, some of the current obstacles of beta cell trans...MORE
A Deeper Look at Immunotherapy Research with Jessica Dunne
Jessica Dunne is a Senior Director of Research at JDRF, focusing on prevention of type 1 diabetes. Recently she spoke with Beyond Type 1 about what it means to prevent T1D, the importance of populatio...MORE
Insulin Access in a Pandemic: An Interview with Wade Neucks of Lilly Diabetes
Beyond Type 1 chatted with Wade Neucks of Lilly Diabetes about expectations of insulin access in the midst of the COVID-19 pandemic.MORE
Dexcom G7 Updates with CEO Kevin Sayer
Dexcom CEO Kevin Sayer discusses Dexcom’s international strategy, the next-generation Dexcom G7, and the response to the Dexcom Follow outage last Fall.MORE
COVID-19 Diabetes Supply Chain Updates
Here, you'll find continuous updates on the status of the diabetes supply chain, with up to date information from all major insulin and device manufacturers as it relates to COVID-19.MORE
COVID-19 Q+A with Endocrinologist Dr. Anne Peters
Dr. Anne Peters, a clinical diabetologist at the USC, recently took the time to answer questions about COVID-19 sourced from the Beyond Type 1 community. MORE
Shoot for the Stars: John Cutter on Living His Dream as a Firefighter with T1D
John Cutter always knew he wanted to be a firefighter when he grew up. But when he was diagnosed with type 1 diabetes, a wrench was thrown into those plans.MORE
Omnipod Closed Loop Technology to be Compatible with Both Abbott and Dexcom CGMs
Abbott and Dexcom announced formal partnerships with Insulet to be compatible as CGMs on the Omnipod Horizon Automated Insulin Delivery System. MORE
Everyone with Diabetes Should Have Access to CGM: Dr. Aaron Neinstein’s Take
Dr. Neinstein was one of four featured experts during Beyond Type 1’s #KnowledgeDrop Series, discussing the future of diabetes care, focusing specifically on technology, data, and emerging therapie...MORE
DKA On The Rise: Dr. Satish Garg Explains Why
"15-20% of Type 2 diabetes cases are misdiagnosed. These patients have antibody positive Type 1 diabetes. So clearly their Type 1 diabetes was totally mistreated and misdiagnosed. That's why...MORE
Addressing the Emotional Side of Diabetes with Dr. Bill Polonksy
"So I started walking around the waiting room and introducing myself to people, saying, 'Hey, could you tell me what's living with diabetes like for you?' And the most remarkable t...MORE
Este Haim On Burnout + Bolusing For Pizza
Este Haim, a member of sister pop trio Haim, talks to Beyond Type 1 about how diabetes burnout influenced her verse on the band's new track "Hallelujah" MORE
One on One with ADA CEO Tracey Brown
Tracey D. Brown is the CEO of the American Diabetes Association. BT1 had a candid conversation with Brown about community needs + what's ahead for the ADA.MORE
Steady Health: A New Type of Diabetes Care
Steady Health offers a new way to manage diabetes, by providing constant access to your care team and a deep analysis of your CGM data. MORE
Implanted PEC-01 Cells Capable of Producing Insulin According to New Data Presented from ViaCyte
ViaCyte presented preliminary data from their PEC-Direct trial, showing that PEC-01 cells are capable of producing insulin in patients with type 1 diabetes.MORE
The Future of Diabetes Care with AADE President Karen Kemmis
Karen Kemmis, the President of AADE recently spoke with Beyond Type 1 about the exciting changes happening at AADE and the future of diabetes care. MORE
Half-Price Generics of NovoLog and NovoLog Mix Announced by Novo Nordisk
Novo Nordisk announced that authorized generic versions of NovoLog and NovoLog Mix will be made available on January 2, 2020.MORE
Senate Bill Aims to Cut Price of Insulin by 75%
The "Insulin Price Reduction Act" would create a new pricing model for insulin, incentivizing manufacturers to lower list prices to 2006 prices.MORE
New Guidance from the US Treasury Opens Door to High Deductible Exemptions for Diabetes Care
The U.S. Treasury issued new guidance which aims to make accessing medications for chronic conditions easier under some insurance plans.MORE
The Future of Dexcom with CEO Kevin Sayer
Beyond Type 1 recently caught up with Dexcom CEO Kevin Sayer to discuss expected updates to G6, the future of Dexcom G7, and continued concerns over access. MORE
One on One With Insulet CEO Shacey Petrovic
Insulet CEO Shacey Petrovic spoke with Beyond Type 1 about her personal connection to T1D, the importance of access, the future of Omnipod and more.MORE
New Senate Bill Would Speed up Availability of Generic Insulin in the U.S.
The Affordable Insulin Approvals Now Act is a bipartisan bill intended to speed up the approval process of generic insulins in order to help lower costs.MORE
JDRF Advocates Urge Congress to Renew Funding for T1D Research
On the final day of the 2019 JDRF Children's Congress, advocates implored the U.S. Special Committee on Aging to renew the Special Diabetes Program.MORE
Dash, Tidepool Loop, Horizon: the Future of Omnipod
The Omnipod Dash is now widely available, and two hybrid closed loops, Omnipod Horizon and DASH + Tidepool are expected in the second half of 2020.MORE
Exciting Trial Results for Tandem’s Control-IQ Hybrid Closed Loop System
Participants using Control-IQ saw an increased time in range, lowered HbA1c, and less time in hyperglycemia and hypoglycemia.MORE
Tidepool and Medtronic Announce Collaboration on Interoperable Automated Insulin Pump
Tidepool announced that they have partnered with Medtronic to create an interoperable automated insulin pump system.MORE
Country Music Star Eric Paslay Talks Life With T1D
Beyond Type 1 recently spoke with Eric Paslay about life with diabetes, the importance of role models, and what he hopes to accomplish with his new podcast.MORE
Actress Jennifer Bartels on Embracing Life with T1D
Beyond Type 1 recently talked to actress Jennifer Bartels about her diagnosis, how she is bringing awareness to T1D, and her plans for the future.MORE
FDA Approves New Treatment for Diabetic Retinopathy
Regeneron Pharmaceuticals announced that the FDA has approved EYLEA (aflibercept) to treat all stages of diabetic retinopathy.MORE
Express Scripts Won’t Cover Lilly’s Generic Insulin
The largest PBM in the U.S. recently released a list of formulary exclusions that included 'Insulin Lispro' as an excluded medication. MORE
DIY Loop Now Compatible with Omnipod
Loop announced a testing branch of its DIY Loop is now compatible with the current 'Eros' generation of Omnipod, and available to the public.MORE
Insulin Manufacturers and PBMs Testify Before Congress
The hearing was contentious throughout, with House members grilling both the manufacturers and the PBM representatives about the reasons for high costs.MORE
JDRF’s New CEO Aaron Kowalski Talks to Beyond Type 1
Beyond Type 1 spoke with newly-appointed JDRF CEO Aaron Kowalski about his priorities, the future of T1D research and treatment options, and how his diabetes has informed his work. MORE
First Oral Medication to Treat T1D Approved in Europe
The European Commission (EC) has approved the use of Forxiga (dapagliflozin) as an add-on treatment to insulin therapy for use in in patients with T1D who have a BMI ≥ 27 kg/m2MORE
Pharma Execs Testify Before Senate on High Drug Prices
Executives from pharmaceutical companies were called on to testify before the Senate Finance Committee to explain the soaring cost of prescription drug prices in the U.S.MORE
Insulin Manufacturers Called on to Explain Skyrocketing Prices
On Tuesday, a group of U.S. Senators led by Patty Murray (D-WA) sent letters to executives at Eli Lilly, Novo Nordisk, and Sanofi demanding information about the rising prices of insulin. MORE
The Future of Glucagon with Xeris CEO Paul Edick
Beyond Type 1 talks to Paul Edick, President and CEO of Xeris Pharmaceuticals, about their revolutionary glucagon pen.MORE
Government Shutdown Leads to Insulin Rationing
Government workers are increasingly unable to afford basic necessities like food, power, and critical medications like insulin.MORE
1 on 1 with Soccer Star Maxim Speed
Maxim Speed is an online sensation who certainly lives up to his name. The 12-year-old from Oahu, Hawaii has been playing soccer practically from the time he could walk. Max recently spoke with Beyond...MORE
Hiking the Appalachian Trail with T1D
When Rachel Hemond set out on her 21st birthday to hike the Appalachian Trail, it was the culmination of a life full of adventure and exploration.MORE
Introducing Francine Kaufman: Newest Member of Science Advisory Council
Meet Francine Kaufman M.D., the newest member of the Beyond Type 1 Science Advisory Council! Dr. Kaufman recently spoke with Beyond Type 1 about her history of treating diabetes, her work abroad, the...MORE
Caitlin Kinnunen: Type 1 on Broadway
Caitlin Kinnunen opens up about The Prom, how she manages her diabetes on stage, the importance of having a strong support system, and her aspirations for the future. MORE
The Deductible Problem
Over the past two decades, deductibles have been steadily rising and a greater percentage of Americans have been enrolling in high deductible health plans.MORE
Runner Spotlight: Gary and Katrina Pilkington
Health and fitness are a priority in Gary and Katrina's lives so that they can set an example for their daughter and inspire others to do the same!MORE
Diabetes Patients Are Being Denied Access to Life-Changing Technology
A recent survey conducted by Dexcom and Beyond Type 1 has revealed that many people with type 1 diabetes are unaware of continuous glucose monitoring.MORE
Runner Spotlight: Patrick Votruba
Beyond Type Run Marathoner Patrick Votruba talks about his diagnosis, experience running in ultra marathons, and how he has been training for the 2018 NYC Marathon.MORE
Runner Spotlight: Léonor Marchand
Léonor Marchand talks with Beyond Type 1 about her running inspiration, how she's preparing for the NYC Marathon, and advice for people living with type 1 diabetes.MORE
Research Shows Fridges Might Be Destroying Insulin
A 16-month study has shown that 79% of insulin is kept at temperatures outside of the recommended range. Insulin stored in the fridge is at a much higher risk. MORE
